INCYTE CORPORATION

Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of various therapeutics in the United States. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera cancers; and Iclusig, a kinase inhibitor to treat chronic myeloid leukemia and philadelphia-chromosome positive acute lymphoblastic leukemia. You have been given clear instructions, reach out to us before it's too late.

The Lash Group, LLC (a Cencora affiliate) reported a cyberattack on Feb 21, 2024, involving exfiltration of personal and health information (names, addresses, DOB, diagnoses, prescriptions) from its patient support programs. 745 Washington residents were affected. Cencora engaged law enforcement and forensic experts, contained the incident, and provided 24 months of credit monitoring.

Cencora, Inc. notified Montana residents of a data security incident involving its Lash Group affiliate. On February 21, 2024, Cencora learned that data from its information systems had been exfiltrated, potentially containing personal information including names, addresses, dates of birth, and health diagnoses/medications. Cencora engaged law enforcement and cybersecurity experts, contained the incident, and offered 24 months of credit monitoring.

Incyte Corporation reported a data breach to the Indiana Attorney General. The breach occurred on 2024-02-21 and was reported on 2024-05-23. 595 Indiana residents were affected.